Björklund Pharma focuses on creating new values for people’s health and well-being by utilizing advances in medicine and life sciences. The company Björklund Pharma is an early-stage biopharmaceutical company with product candidates within the following therapeutic areas:

• Psychiatry
• Neurology
• Pain
• Sleep
• Dermatology
• Ophthalmology
• Cardiology
• Gastrointestinal
• Immunology
• Infectious diseases
• Metabolic disorders
• Toxicology
• Pulmonology/respiratory
• Renal/hepatic
• Nutraceuticals

Most of the company’s product candidates are in an early preclinical stage. During the preclinical phase, various tests and experiments will be conducted to determine drugs’ safety, effectiveness, and how they are metabolized in the body. This information will be used to design and plan clinical trials to test the drugs on human subjects.